News
Racial, age disparities confirmed in triple-negative breast cancer
- Author:
- Susan London
In a cohort of more than a million breast cancer cases, likelihood of having a tumor with the TNBC phenotype was roughly twice as high for black...
News
Vemurafenib has durable activity in NSCLC harboring BRAF V600 mutations
- Author:
- Susan London
More than a third of patients had a complete or partial response to monotherapy with the oral BRAF(V600E) kinase inhibitor, and median overall...
News
Multigene panel sequencing is moderately cost-effective in NSCLC
- Author:
- Susan London
Compared with a single-marker approach, a multigene panel approach had an incremental cost-effectiveness ratio of about $148,000 per life-year...
News
EHR default order slashes unnecessary imaging during palliative RT
- Author:
- Susan London
After implementation of the default order specifying no daily imaging during palliative radiation therapy, patients were 63% less likely to...
News

Specific prednisone regimen safer than others when used with abiraterone for mCR prostate cancer
- Author:
- Susan London
Prednisone, 5 mg, twice daily, gave the most favorable overall safety profile when with regard to avoiding mineralocorticoid excess and long-term...
News
Liquid biopsy assays found sensitive for NSCLC EGFR mutations
- Author:
- Susan London
Two liquid biopsy assays performed well at detecting EGFR mutations in plasma-derived cell-free DNA from patients with NSCLC, possibly...
News
Immunotherapy-treated NSCLC: Adverse impact of steroids driven by palliative indications
- Author:
- Susan London
A new analysis suggests use of steroids for cancer-related palliation in patients with poor prognosis largely explains their association with...
News
Niraparib-pembrolizumab combo finds niche in breast, ovarian cancers
- Author:
- Susan London
The combination had good antitumor activity, as well as good safety and tolerability, in patients with advanced TNBC or ovarian carcinoma who were...
News
Neoadjuvant-adjuvant erlotinib shows promise in locally advanced NSCLC
- Author:
- Susan London
The EMERGING trial failed to meet its primary endpoint of higher OR but did meet the secondary endpoint of longer PFS.
News
Study raises questions about PPS exemption for cancer centers
- Author:
- Susan London
Hospitals affiliated with PPS-exempt cancer centers and hospitals affiliated with NCI cancer centers were similar on most metrics.
News
Low-dose CT lung cancer screening nets payoff in community setting too
- Author:
- Susan London
A survey of 165 lung cancer screening centers suggests low-dose CT screening is being effectively implemented in community practices, replicating...
News

Syncope during pregnancy increases risk for poor outcomes
- Author:
- Susan London
Syncope during pregnancy is not as benign as once thought, carrying higher risks of preterm birth, congenital anomalies, and postpartum cardiac...
News
Use of Oncotype DX to tailor breast cancer treatment likely to reduce costs
- Author:
- Susan London
In the wake of the TAILORx trial, routine use of Oncotype DX in women with early breast cancer is expected to increase testing costs but decrease...
News

Post-treatment persistence of oral HPV in HNSCC predicts recurrence, death
- Author:
- Susan London
Patients who still had detectable oral HPV DNA after primary treatment had a more than tripling of risk of recurrence-free survival events and a...
News
Oropharynx cancer burden is shifting to older men
- Author:
- Susan London
Increasing incidence of oropharynx cancer in individuals born after 1955 has slowed, whereas incidence continues to rise among individuals born...